Brief: Santhera Pharmaceuticals Says Idorsia Receives $30 Mln From R-Bridge For Agamree Royalties
Jan 16 (Reuters) - Santhera Pharmaceuticals Holding AG
SANN.S :
* SANTHERA PHARMACEUTICALS PROVIDES UPDATE ON ROYALTY
AGREEMENT
FOR AGAMREE® (VAMOROLONE) AND WARRANTS HELD BY IDORSIA
* SANTHERA PHARMACEUTICALS HOLDING AG - IDORSIA RECEIVES $30
MILLION FROM R-BRIDGE FOR AGAMREE ROYALTIES
Source text: ID:nGNX7db8HC
Further company coverage: SANN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Santhera Pharmaceuticals Holding AG
See all newsSwitzerland's Santhera Pharma H1 revenue soars on AGAMREE sales, milestones
Brief: Santhera Pharmaceuticals H1 Operating Income CHF -6.562 Million
Brief: Santhera Says NXERA Plans To Submit South Korea Marketing Authorization Application 2026
Brief: Santhera Gets Positive CHMP Opinion To Expand Agamree (Vamorolone) Use
Brief: Santhera Pharmaceuticals H1 Operating Income CHF -35.444 Million